Bringing teams together
Collaborating for success
Interfacing with industry
Harnessing translational science
Advancing healthcare solutions
What is GMEC?
The Global Medical Excellence Cluster (GMEC) is a not-for-profit company formed by its founder universities to develop a framework within which universities, commercial organisations and National Health Service Trusts can collaborate to accelerate progress in Translational Medicine, bolster the UK’s globally competitive position in biomedical research, attract inward investment and improve patient outcomes.
Founded by five of the world’s top universities, Cambridge University, Imperial College London, King’s College London, Oxford University and University College London the company was joined by Queen Mary University of London in 2012.
GMEC is open for proposals from healthcare companies to devise and implement projects which will create new cross- sector opportunities in biomedical research.
- Friedreich’s Ataxia Research Collaboration Programme Announced
- GMEC/Pfizer Rare Disease Collaboration: University of Oxford and Pfizer Sign First Research Projects
- GMEC/Pfizer Rare Disease collaboration named in Top Seven Worldwide Academic Alliances
- GMEC announces agreement with Pfizer Inc. in Rare Disease research